These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 12703164)

  • 21. Review series: the politics of TB: the politics, economics and impact of directly observed treatment (DOT) in India.
    Udwadia ZF; Pinto LM
    Chron Respir Dis; 2007; 4(2):101-6. PubMed ID: 17621578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru.
    Chavez Pachas AM; Blank R; Smith Fawzi MC; Bayona J; Becerra MC; Mitnick CD
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):52-8. PubMed ID: 14974746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?
    Di Perri G; Bonora S
    J Antimicrob Chemother; 2004 Sep; 54(3):593-602. PubMed ID: 15282233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-line antituberculosis drug resistance prevalence and its pattern among HIV-infected patients in the national referral tuberculosis centre, Iran.
    Tabarsi P; Chitsaz E; Moradi A; Baghaei P; Farnia P; Marjani M; Irannejad P; Mansouri D; Masjedi M
    Int J STD AIDS; 2009 Aug; 20(8):566-70. PubMed ID: 19625590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycobacterium tuberculosis in Taiwan.
    Hsueh PR; Liu YC; So J; Liu CY; Yang PC; Luh KT
    J Infect; 2006 Feb; 52(2):77-85. PubMed ID: 16216328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
    Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
    Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
    Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuberculosis drug resistance: a global threat.
    Nachega JB; Chaisson RE
    Clin Infect Dis; 2003 Jan; 36(Suppl 1):S24-30. PubMed ID: 12516027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of cutaneous tuberculosis.
    Handog EB; Gabriel TG; Pineda RT
    Dermatol Ther; 2008; 21(3):154-61. PubMed ID: 18564245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospects for new tuberculosis treatment in Africa.
    Mwinga A; Bernard Fourie P
    Trop Med Int Health; 2004 Jul; 9(7):827-32. PubMed ID: 15228494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-resistant tuberculosis.
    Goble M
    Semin Respir Infect; 1986 Dec; 1(4):220-9. PubMed ID: 3685667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on the treatment of tuberculosis.
    Inge LD; Wilson JW
    Am Fam Physician; 2008 Aug; 78(4):457-65. PubMed ID: 18756652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of TB suspected cases of drug resistant tuberculosis requiring a second treatment].
    Caminero JA
    Biomedica; 2004 Jun; 24 Supp 1():212-27. PubMed ID: 15495588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Likelihood of generating MDR-TB and XDR-TB under adequate National Tuberculosis Control Programme implementation.
    Caminero JA
    Int J Tuberc Lung Dis; 2008 Aug; 12(8):869-77. PubMed ID: 18647445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-resistant tuberculosis: controversies and challenges in pediatrics.
    Smith KC; Seaworth BJ
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):995-1010. PubMed ID: 16307511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TB treatment evolves.
    Huff B
    GMHC Treat Issues; 2003 Oct; 17(10):4-5. PubMed ID: 14689926
    [No Abstract]   [Full Text] [Related]  

  • 39. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of multi-drug resistant tuberculosis: practitioner's view point.
    Prasad R
    Indian J Tuberc; 2007 Jan; 54(1):3-11. PubMed ID: 17455417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.